Press Release

Kanxi Liao
Mr. Liao specializes in general banking matters, fintech, asset management transactions, blockchain and cryptocurrency, real property finance, and financial institution set-up and investment. Mr. Liao represents various commercial banks in a variety of financing transactions, including structured finance, acquisition finance, and real property finance. Mr. Liao assists fintech enterprises in product design and compliance, investing in fintech enterprises, investing in and setting up financial institutions. Mr. Liao also represents trust companies in a variety of domestic and cross-border asset management transactions.

Yuan Meng
Ms. Meng specializes in aviation finance, bank finance, financial institution establishment, and corporate compliance. She is knowledgeable of relevant PRC industry policies, corporate structures, and investment and project management and has extensive practical experience. Ms. Meng represents clients in leasing and financing projects involving various types of aeronautical facilities and other high-value equipment. She has advised on a wide range of financing transactions such as bilateral loans, syndicated loans, trade finance, as well as convertible bond transactions, leveraged finance, and non-performing asset disposals.

Jinsong (Jason) Song
Mr. Song specializes in private equity and venture capital, mergers and acquisitions, foreign investment, and capital markets, among other areas. He has represented institutional investors and corporate clients in over a hundred transactions in diverse industries such as internet, telecommunications, bio-medicine, consumer goods, automotive logistics, energy, education, gaming, real estate, and fintech, providing full-scope legal services spanning deal structure design, legal document drafting and negotiation, and project closing.

Dan Sun
Ms. Sun specializes in public and private financing, mergers and acquisitions, incorporation and corporate restructuring, and foreign direct investment. She has represented Chinese and international companies in a wide variety of cross-border transactions in diverse industries such as telecommunications, internet, consumer goods, healthcare, biotechnology, and pharmaceuticals.

Lijuan Wang
Ms. Wang's primary practice areas are mergers, acquisitions and reorganizations, private equity and venture capital, and foreign investment. She is knowledgeable of relevant industry policies, corporate structures, and project management and has extensive practical experience. Ms. Wang has developed a broad client base consisting of multinationals, foreign-invested companies, leading funds, as well as SOEs and start-ups. Ms. Wang also focuses on the areas of life sciences, bio-medicine and healthcare, advising clients on corporate, compliance and transaction issues such as those related to the biosecurity law and human genetic resources, clinical trials, product marketing authorization, GxP compliance, healthcare data compliance, exclusive product distribution, as well as cross-border drug and patent right license-in and commercialization projects.